Cannabis producer Organigram Holdings (NASDAQ:OGI,TSX:OGI) issued a surprise projection, saying that it expects a drop in net revenues in its fourth fiscal quarter of the year.

On Monday (November 11), the Quebec-based licensed producer informed investors it expects to report net revenues of C$16.3 million in Q4 — approximately C$8.5 million lower than its Q3 net revenues.

As a result, Organigram now expects to see negative adjusted earnings before interest, tax, depreciation and amortization (EBITDA). Greg Engel, CEO of the firm, noted despite the disappointing news, the company still anticipates it will have a positive adjusted EBITDA for the entire year.

As of Tuesday’s (November 12) open, shares of the company had dropped dramatically. In New York, the company opened at US$2.79, representing a loss in value of 11.65 percent from its previous close.

In Toronto, the firm was down early to a price of C$3.94, a decline of 11.66 percent or C$0.52 per share.

The company has attributed the slowdown to the usual myriad of issues affecting the legalized industry in Canada, such as the troubled retail rollout in Ontario — a key province for the marijuana market.

“The lack of a sufficient retail network and slower than expected store openings in Ontario continued to impact sales in Q4 2019 and were further exacerbated by increased industry supply,” Organigram said in its Monday statement.

Despite the current landscape in Ontario, Engel said he is encouraged by the possibility of changes coming to the prominent Canadian province.

“We are encouraged by Ontario’s recent announcement to expand the retail network and believe this should be an important catalyst to drive further growth for us and the industry as a whole,” he said.

Earlier in November, a collection of CEOs of cannabis licensed producers signed a joint letter to Ontario Premier Doug Ford requesting the full opening of the provincial retail market as a way to aid the entire cannabis market in the country.

Organigram confirmed that it has submitted product notices to Health Canada for a collection of vape pens and cannabis-infused chocolates, and expects to see these items available in calendar Q1 2020.

The producer also now plans to see a “water-compatible, flavorless nano-emulsion powdered beverage product” line available on store shelves by Q2 2020.

Organigram will release its entire earnings report for the most recent period and its entire operational year, which ended on August 31, on November 25.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.

A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.

Keep reading... Show less

The product will include polyphenols known to have significant health benefits.

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).

Keep reading... Show less

 Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) (“Canopy Growth” or “the Corporation”) announced today that EVP & CFO Mike Lee will be participating in a fireside chat at the BofA Securities Virtual Consumer & Retail Technology Conference on Thursday, March 11, 2021 at 9:30am ET .

Keep reading... Show less

Hill Street Beverage Company Inc. (TSXV: BEER) (“Hill Street” or the “Company”). The Company announces that further to its press release dated March 2, 2021, it has obtained TSX Venture Exchange approval to extend the closing date of its previously announced private placement of units (“Units”) until April 7, 2021. Each Unit is comprised of one (1) common share and one (1) warrant, exercisable for one common share at price of $0.11 per share, for a period of three (3) years from the date of Closing. The Company applied to extend the date of closing to allow a greater number of interested investors to participate.

For more information regarding the Company or the offering, please contact, or

Keep reading... Show less